VR and AR in Healthcare: Accessibility and Inclusion as the Next Frontier

For years, VR headsets in clinics were treated as novelties - something to showcase at a medical expo or to entertain patients while they waited. That era is over. Immersive technologies are now part of real clinical protocols: reducing chronic pain, expanding access to rehabilitation, and even helping doctors collaborate across continents. Yet the future of VR and AR in medicine will not be decided by graphics resolution or headset design.

The true competitive edge and the ethical imperative lie in accessibility and inclusion. The question is no longer “can VR work?” but “who can access it, under what conditions, and with what outcomes?”

The U.S. Veterans Health Administration has already deployed immersive tools across all 50 states and Puerto Rico, not as experiments but as standard programs for pain, PTSD, and training. Their example highlights a turning point: immersive care can scale only if it is inclusive by design, reaching rural patients, people with mobility limitations, or those who might otherwise be left out of modern healthcare.

This article examines that shift. We will look at where VR and AR are delivering real value, how accessibility challenges could undermine progress, and why inclusion is the next frontier for digital health companies working in immersive care.

Who Gets to Benefit? The Real Question Behind XR in Healthcare

When we talk about VR and AR in medicine, the conversation often jumps straight to technology: higher resolution displays, lighter headsets, faster processors. But the real frontier isn’t technical, it’s social. The pressing question is: who actually gets to benefit?

Before diving deeper, let’s clarify the terms. Virtual Reality (VR) places users in a fully simulated environment, while Augmented Reality (AR) overlays digital information on the real world. Together, these and related technologies are often referred to as Extended Reality (XR) - an umbrella term for immersive tools that blend physical and digital experiences.

Today, access to advanced care still depends heavily on where you live, what you earn, and whether you can physically reach a hospital. Immersive tools promise to break those boundaries - a veteran with chronic pain in a rural county can receive therapy in their living room, just like someone living next to a major clinic. That’s the transformative power of XR: not just creating new treatments, but extending existing ones to people who were previously excluded.

Yet accessibility is also about biology and design. Motion sickness keeps many patients, particularly women, from using headsets for long periods. Interfaces that ignore low vision or hearing needs quietly push whole groups of patients aside. Even cultural design matters: a “rehab game” that feels natural to one community may seem confusing or alienating to another.

The opportunity is clear. If healthcare XR is built with inclusivity at its core, it becomes a genuine equalizer. If not, it risks turning into another shiny tool that only a fraction of patients can use. The future of VR and AR in healthcare will be defined less by its technology and more by its ability to reach the people who need it most.

When Inclusion Translates Into Real-World Impact

The most convincing evidence for immersive healthcare doesn’t come from glossy demos - it comes from patients whose daily lives are different because these tools meet them where they are. Consider pain management: in 2021, the FDA cleared a VR-based therapy for chronic low back pain, designed to be used entirely at home. For patients who can’t easily travel or who want to avoid opioids, that shift is more than convenient; it’s life-changing.

In burn units, immersive distraction has already been shown to cut pain during wound care by nearly half. For patients who are poor candidates for heavy sedation, this isn’t just an alternative treatment; it’s an inclusive pathway that opens care to people who might otherwise suffer through unbearable procedures.

Rehabilitation tells a similar story. Stroke survivors often face long, exhausting journeys to regain function, and many live far from specialist clinics. Virtual rehab programs, some already tested by Veterans Affairs, bring therapy into the home, with progress monitored remotely. Here, inclusion means older adults with limited mobility don’t have to travel repeatedly to urban hospitals; therapy adapts to them, not the other way around.

Even vision loss, one of the hardest barriers to overcome, is being addressed. Trials at Moorfields Eye Hospital in London have shown that head-mounted AR systems can significantly improve visual acuity for people with severe impairment, helping them read or recognize faces again. And when platform providers like Apple build accessibility features directly into their operating systems, it signals a cultural shift: immersive medicine isn’t a side experiment, it’s being designed to be universal.

Across these examples, the pattern is clear. XR isn’t only about delivering better care; it’s about delivering care more fairly. Every successful clinical case that centers accessibility pushes the field closer to its real promise: a healthcare system that adapts to the patient, not the other way around.

Inclusion as a Market Driver: What It Means for Healthtech and Investors

For healthtech companies, accessibility is no longer a side feature; it’s a market signal. Regulators, payers, and hospital systems increasingly ask the same question: can this technology realistically be used by a diverse population of patients, or only by a narrow slice? Products that answer inclusively are the ones that move beyond pilot projects and into real adoption.

From an investment perspective, the numbers are compelling. The global VR in healthcare market, valued at around $2 billion in 2022, is projected to exceed $20 billion within a decade. But that growth will not come from high-end, one-off surgical applications alone. It will be fueled by scalable, reimbursable, and accessible solutions - digital therapeutics for chronic conditions, remote rehabilitation platforms, and training systems deployable in both top-tier hospitals and rural clinics.

Accessibility also expands the addressable market. A VR therapy that is simple enough for older adults, adaptable for patients with sensory impairments, and optimized for low-bandwidth environments is not just “ethical design” - it’s a product that can serve millions more users. That kind of universality is exactly what payers and governments look for when deciding which tools to cover.

Investors, in turn, are watching for signals of scalability and inclusion. When Highmark began reimbursing RelieVRx in 2024, it wasn’t only a milestone for AppliedVR - it was a proof point that inclusive design can break through one of the hardest barriers in digital health: payer coverage. Similar momentum is visible in Europe and Asia, where national health systems see XR as a way to stretch limited clinical workforces further.

In practical terms, this means startups that bake accessibility into their roadmap - multilingual interfaces, low-cost hardware options, customizable user experiences - will not only differentiate technically but also position themselves as the safer bet for investors. Conversely, those who treat accessibility as an afterthought risk building tools that impress in demo halls but never survive procurement committees.

For the healthtech market, inclusion is fast becoming what cybersecurity is in fintech: a non-negotiable. It doesn’t just protect against failure; it creates the conditions for sustainable growth.

The Next Five Years: From Experiments to Everyday Care

The story of VR and AR in healthcare is moving quickly from proof-of-concept to standard of care. In the next five years, we are likely to see immersive therapies written into clinical guidelines, bundled into reimbursement models, and prescribed as naturally as physical therapy or medication. The difference between winners and laggards in this space will not be the novelty of their graphics or the sophistication of their hardware; it will be how deeply accessibility is built into their DNA.

Expect to see digital therapeutics in VR prescribed for chronic pain, anxiety, and rehab on a wide scale, with coverage not only from forward-looking private insurers but also from national health systems under pressure to deliver more with less. AR tools will expand in surgical settings and frontline care, particularly where staff shortages make telepresence and remote mentoring essential. And accessibility requirements - captions, haptic alternatives, low-cost delivery models - will become baseline expectations rather than differentiators.

For investors and innovators, the opportunity is clear. Products that demonstrate inclusivity will scale fastest, both geographically and demographically. Those that fail to do so will be sidelined, much like early telemedicine platforms that ignored ease of use. The healthcare market is unforgiving toward tools that work only in ideal conditions.

Ultimately, the next frontier for XR in medicine is not spectacle, but equity. The companies that recognize this - and design not just for patients but with them - will define the future. Five years from now, we may look back and realize that the most radical promise of immersive technology was never immersion itself, but the simple fact that it made quality care reachable by everyone.